Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. - Soloway,M.S.; Briggman,J.V.; Carpinto,G.A. (J Urol, 1996)